Use of High-dose Oxazaphosphorine Drugs for Treating Immune Disorders
This disclosure relates, at least in part, to methods of eliminating adverse immune reactions in a subject in need thereof including those associated with autoimmune diseases, allergic reactions and transplant rejection, including administration of a lymphocytotoxic non-myeloablative amount of a oxazaphosphorine drug to the subject.
BRODSKY ROBERT A [US]; JONES RICHARD J [US]
Type of Offer:
« More Life Sciences Patents